These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16634751)

  • 1. Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers.
    Fontana P; Nolli S; Reber G; de Moerloose P
    J Thromb Haemost; 2006 Apr; 4(4):813-9. PubMed ID: 16634751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the response to aspirin and clopidogrel vary over 6 months in patients with ischemic heart disease?
    Khanna V; Mikael R; Thayalasamy K; Sambu N; Dimitrov BD; Englyst N; Calver AL; Corbett S; Gray H; Simpson IA; Wilkinson JR; Curzen N
    J Thromb Haemost; 2015 Jun; 13(6):920-30. PubMed ID: 25809653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study.
    Eriksson AC; Jonasson L; Lindahl TL; Hedbäck B; Whiss PA
    J Transl Med; 2009 Jun; 7():42. PubMed ID: 19508722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
    Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
    Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance.
    Frelinger AL; Furman MI; Linden MD; Li Y; Fox ML; Barnard MR; Michelson AD
    Circulation; 2006 Jun; 113(25):2888-96. PubMed ID: 16785341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of aspirin responsiveness by use of whole blood platelet aggregometry.
    Ivandic BT; Giannitsis E; Schlick P; Staritz P; Katus HA; Hohlfeld T
    Clin Chem; 2007 Apr; 53(4):614-9. PubMed ID: 17332149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.
    Lepäntalo A; Virtanen KS; Reséndiz JC; Mikkelsson J; Viiri LE; Karhunen PJ; Lassila R
    Thromb Res; 2009 Jun; 124(2):193-8. PubMed ID: 19232433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing multiplate whole blood impedance platelet aggregometry measurements, during aspirin treatment in acute ischemic stroke: a pilot study.
    Jastrzębska M; Chełstowski K; Wódecka A; Siennicka A; Clark J; Nowacki P
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):830-8. PubMed ID: 24071649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of the anti-platelet effects of aspirin and clopidogrel.
    Li C; Hirsh J; Xie C; Johnston MA; Eikelboom JW
    J Thromb Haemost; 2012 Apr; 10(4):521-8. PubMed ID: 22268852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in thromboxane B2 concentrations in serum and plasma in patients taking regular aspirin before and after clopidogrel therapy.
    Good RI; McGarrity A; Sheehan R; James TE; Miller H; Stephens J; Watkins S; McConnachie A; Goodall AH; Oldroyd KG
    Platelets; 2015; 26(1):17-24. PubMed ID: 24433337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clopidogrel and aspirin in cardiovascular medicine: responders or not--current best available evidence.
    Tourmousoglou CE; Rokkas CK
    Cardiovasc Hematol Agents Med Chem; 2008 Oct; 6(4):312-22. PubMed ID: 18855644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin.
    De Kam PJ; Luo WL; Wenning L; Ratcliffe L; Sisk CM; Royalty J; Radziszewski W; Wagner JA; Lai E
    Platelets; 2014; 25(7):480-7. PubMed ID: 24206527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension.
    Robbins IM; Kawut SM; Yung D; Reilly MP; Lloyd W; Cunningham G; Loscalzo J; Kimmel SE; Christman BW; Barst RJ
    Eur Respir J; 2006 Mar; 27(3):578-84. PubMed ID: 16507859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual antiplatelet response during PCI: VerifyNow P2Y12 predicts myocardial necrosis and thromboxane B2 generation confirms wide variation in aspirin response.
    Good RI; McGarrity A; James TE; Miller H; McConnachie A; Goodall AH; Oldroyd KG
    Thromb Res; 2015 Jun; 135(6):1140-6. PubMed ID: 25746368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of turbidimetric aggregation and in vitro bleeding time (PFA-100) for monitoring the platelet inhibitory profile of antiplatelet agents in patients undergoing stent implantation.
    Van der Planken MG; Claeys MJ; Vertessen FJ; Dilling D; Bosmans JM; Berneman ZN; Michiels JJ; Vrints C
    Thromb Res; 2003; 111(3):159-64. PubMed ID: 14678814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study.
    Campo G; Valgimigli M; Gemmati D; Percoco G; Catozzi L; Frangione A; Federici F; Ferrari F; Tebaldi M; Luccarelli S; Parrinello G; Ferrari R
    J Am Coll Cardiol; 2007 Sep; 50(12):1132-7. PubMed ID: 17868803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.
    Lin J; Han Z; Wang C; Yi X; Chai Z; Zhou Q; Huang R
    Eur J Clin Pharmacol; 2018 Sep; 74(9):1131-1140. PubMed ID: 29804161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clopidogrel inhibits platelet aggregation in patients on aspirin with stable chronic angina pectoris.
    Saha S; Berglund M; Sylvén C; Gordon A; Agewall S
    Int J Cardiol; 2008 Jan; 123(2):195-6. PubMed ID: 17320208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance--the BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy.
    Neubauer H; Kaiser AF; Endres HG; Krüger JC; Engelhardt A; Lask S; Pepinghege F; Kusber A; Mügge A
    BMC Med; 2011 Jan; 9():3. PubMed ID: 21226927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of 96-well plate aggregometry and measurement of thrombi adhesion to determine aspirin and clopidogrel effectiveness.
    Armstrong PC; Dhanji AR; Truss NJ; Zain ZN; Tucker AT; Mitchell JA; Warner TD
    Thromb Haemost; 2009 Oct; 102(4):772-8. PubMed ID: 19806265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.